https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
Background Objective data on chemosensitive disorders during COVID-19 are lacking in the Literature. Methods Multicenter cohort study that involved four Italian hospitals. Three hundred and forty-five COVID-19 patients underwent objective chemosensitive evaluation. Results Chemosensitive disorders self-reported by 256 patients (74.2%) but the 30.1% of the 89 patients who did not report dysfunctions proved objectively hyposmic. Twenty-five percentage of patients were seen serious long-lasting complaints. All asymptomatic patien